New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 85d ago.

Abstract

OPEN

Commenters (1)

• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%